Sonova Holding AG (SOONN) Stock Price & Analysis
SOONN Stock Chart & Stats
- Day’s Range
- MXN 5,950.29 - MXN 5,950.29
- 52-Week Range
- MXN 5,394.06 - MXN 5,950.29
- Previous Close
- MXN 5,950.29
- Volume
- N/A
- Average Volume (3M)
- 6
- Market Cap
- MXN 371.84B
- Enterprise Value
- MXN 11.68B
- Total Cash (Recent Filing)
- MXN 722.10M
- Total Debt (Recent Filing)
- MXN 1.71B
- Price to Earnings (P/E)
- 39.3
- Beta
- 0.09
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- 103.94
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.21%
Bulls Say, Bears Say
Bulls Say
Hearing Instruments Growth
The core hearing-instruments business is showing strong demand and operating leverage, with profit growing substantially faster than revenue. Sustained product adoption and margin expansion can strengthen Sonova’s earnings base and provide resources for continued innovation and market-share gains.
Market Share And Channel Expansion
Double-digit wholesale growth and reported market-share gains indicate that Sonova’s brands, technology portfolio, and professional distribution network remain competitive. This broad channel momentum supports durable customer reach and improves the potential for recurring upgrades across future product platforms.
Cash Generation
High cash conversion demonstrates that reported earnings are translating into usable cash, supporting investment, acquisitions, and shareholder distributions without relying solely on external financing. Disciplined capital spending further reinforces financial flexibility as Sonova funds product development and retail expansion.
Bears Say
Cochlear Implant Weakness
The cochlear-implant business is experiencing simultaneous pressure from reimbursement changes, weaker upgrade demand, and competition. Because this segment contributes specialized products and future growth potential, prolonged weakness could dilute group growth and require additional investment to restore competitiveness.
Recent Revenue And Margin Pressure
The recent top-line decline and lower net margin show that Sonova’s historically strong profitability has not been fully immune to slower growth and changing mix. If this pattern persists, reduced operating leverage could limit earnings expansion and weaken the company’s ability to absorb business pressures.
Non-recurring Cost Burden
The scale and variety of recent exceptional charges demonstrate that reported performance has been affected by legal, legacy liability, and asset-quality issues. Although classified as non-recurring, expected non-core items of CHF 35–40 million indicate continued pressure on earnings quality and management’s capital allocation.
Sonova Holding AG News
SOONN FAQ
What was Sonova Holding AG’s price range in the past 12 months?
What is Sonova Holding AG’s market cap?
When is Sonova Holding AG’s upcoming earnings report date?
How were Sonova Holding AG’s earnings last quarter?
Is Sonova Holding AG overvalued?
Does Sonova Holding AG pay dividends?
What is Sonova Holding AG’s EPS estimate?
How many shares outstanding does Sonova Holding AG have?
What happened to Sonova Holding AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sonova Holding AG?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sonova Holding AG
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Eric Alain Bernard
- Employees
- 18,580
- Website
- www.sonova.com
- Address
- Laubisrutistrasse 28, Stäfa, ZH, 8712, CH
Sonova Holding AG (SOONN) Earnings & Revenues
SOONN Earnings Call
Earnings Call SentimentPositive
The call presented a clearly positive operational and financial picture: above-market sales growth, strong wholesale momentum and market-share gains, significant margin expansion, robust cash conversion and a confident guidance range. Key negatives are concentrated in the Cochlear Implants business (declining sales and margins), substantial non‑recurring charges and FX headwinds, and timing/regulatory risk around the planned CI product launch. On balance, the company showed broad-based momentum and multiple levers (product pipeline, retail M&A, efficiency initiatives) to drive future growth, outweighing the identified headwinds.
View all MX:SOONN earnings summariesSOONN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 1 | 2 |
| Technical Analysis | 2 | 1 | 2 |
| Moving Averages | 12 | 0 | 0 |
